Integrated Actionable Aging Assessment for Cancer Patients Pilot

Launched by UNIVERSITY OF COLORADO, DENVER · May 12, 2023

Keywords

ClinConnect Summary

This clinical trial, called the Integrated Actionable Aging Assessment for Cancer Patients Pilot (IA3-CP), is focused on improving care for older adults with various types of cancer, including breast cancer, prostate cancer, and leukemia. The goal of the study is to create a better way for doctors to assess the unique needs of older cancer patients by looking not only at their medical condition but also at their mental health, social circumstances, and everyday health behaviors. By gathering this important information in a structured way, the hope is to help doctors provide more personalized treatment plans and improve communication between patients and their healthcare teams.

To participate in this study, individuals must be at least 65 years old, speak either English or Spanish, and be attending their first visit to an oncology clinic. Participants will be asked to engage in various assessments related to their health and well-being. The researchers are currently recruiting participants and aim to determine if this new approach can be consistently used in clinical settings to enhance the quality of care for older cancer patients. It's an exciting opportunity to contribute to better healthcare for those facing cancer as they age.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \> /= 65
• • Patient must agree to participate in all study-related activities
• • English or Spanish speaking
• • Attending initial visit to oncology
• • Exclusion criteria
• • age \< 65
• • primary language other than English or Spanish